Detalhe da pesquisa
1.
3-year invasive disease-free survival with chemotherapy de-escalation using an 18F-FDG-PET-based, pathological complete response-adapted strategy in HER2-positive early breast cancer (PHERGain): a randomised, open-label, phase 2 trial.
Lancet
; 403(10437): 1649-1659, 2024 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38582092
2.
Explainable clinical coding with in-domain adapted transformers.
J Biomed Inform
; 139: 104323, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36813154
3.
Design and implementation of a standard care programme of therapeutic exercise and education for breast cancer survivors.
Support Care Cancer
; 30(2): 1243-1251, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34463835
4.
Chemotherapy de-escalation using an 18F-FDG-PET-based pathological response-adapted strategy in patients with HER2-positive early breast cancer (PHERGain): a multicentre, randomised, open-label, non-comparative, phase 2 trial.
Lancet Oncol
; 22(6): 858-871, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34019819
5.
Structural validity and reliability of the Spanish Central Sensitization Inventory in breast cancer survivors.
Pain Pract
; 21(7): 740-746, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33768652
6.
Efficacy and safety of dasatinib with trastuzumab and paclitaxel in first line HER2-positive metastatic breast cancer: results from the phase II GEICAM/2010-04 study.
Breast Cancer Res Treat
; 174(3): 693-701, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30607629
7.
High Proliferation Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Early Breast Cancer.
Oncologist
; 21(2): 150-5, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26786263
8.
Increasing Annual Cancer Incidence in Patients Age 20-49 Years: A Real-Data Study.
JCO Glob Oncol
; 10: e2300363, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38513186
9.
Optimal [18F]FDG PET/CT Cutoff for Pathologic Complete Response in HER2-Positive Early Breast Cancer Patients Treated with Neoadjuvant Trastuzumab and Pertuzumab in the PHERGain Trial.
J Nucl Med
; 65(5): 708-713, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38575192
10.
Pattern of recurrence of early breast cancer is different according to intrinsic subtype and proliferation index.
Breast Cancer Res
; 15(5): R98, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24148581
11.
Factors associated with upper limb function in breast cancer survivors.
PM R
; 15(2): 151-156, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34713595
12.
Validation of the Upper Limb Functional Index on Breast Cancer Survivor.
Int J Environ Res Public Health
; 20(6)2023 03 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36981904
13.
SEOM-GEICAM-SOLTI clinical guidelines in advanced breast cancer (2022).
Clin Transl Oncol
; 25(9): 2665-2678, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37148499
14.
Male breast cancer: immunohistochemical subtypes and clinical outcome characterization.
Oncology
; 83(4): 228-33, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22907070
15.
Role of germline variants in the metastasis of breast carcinomas.
Oncotarget
; 13: 843-862, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35782051
16.
High Proliferation Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Early Breast Cancer.
Oncologist
; 21(6): 778, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27317735
17.
Outcome of small invasive breast cancer with no axillary lymph node involvement.
Breast J
; 17(1): 32-8, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21129091
18.
Significant Decrease in Annual Cancer Diagnoses in Spain during the COVID-19 Pandemic: A Real-Data Study.
Cancers (Basel)
; 13(13)2021 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34203185
19.
Regulatory CDH4 Genetic Variants Associate With Risk to Develop Capecitabine-Induced Hand-Foot Syndrome.
Clin Pharmacol Ther
; 109(2): 462-470, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32757270
20.
Machine learning and natural language processing (NLP) approach to predict early progression to first-line treatment in real-world hormone receptor-positive (HR+)/HER2-negative advanced breast cancer patients.
Eur J Cancer
; 144: 224-231, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33373867